United states report from a physician on 04-nov-2020.
A physician reported that a female patient (unknown age) received rha on an unknown date; with unknown dose, frequency and for labial folds.
An unknown volume of rha product was injected into the labial folds.
The technique used for administration of rha was unknown and it was not known if a cannula was used for the administration of the rha product.
Previous cosmetic procedures, medical history and concomitant medications and food supplements were not provided.
An unspecified period of time following the injection of rha, the patient experienced an occlusive event in the nlf which blocked the angular artery.
On an unknown date, an unknown substance was used to dissolve the occlusion.
It was clarified that the patient was "fine", but no further clarification was provided as to whether the event was resolved.
The outcome of the event was unknown.
The intensity of the event was not provided.
It was unknown if the product was available for return.
Health effect: (b)(4).
No additional information was available at the time of this report.
|